These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 2002856)

  • 1. [Zidovudine treatment and need of blood transfusion in patients with AIDS].
    Ligtenberg PC; Hoepelman IM; Vrehen HM; Borleffs JC
    Ned Tijdschr Geneeskd; 1991 Jan; 135(4):130-3. PubMed ID: 2002856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Zidovudine therapy in 141 patients with symptoms of HIV infection; a multicenter study].
    Perenboom R; Reiss P; Danner SA; van 't Wout JW
    Ned Tijdschr Geneeskd; 1990 Jan; 134(3):120-4. PubMed ID: 2405287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
    Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B
    Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice.
    Colson ER; Horwitz RI; Bia FJ; Viscoli CM
    Arch Intern Med; 1991 Apr; 151(4):709-13. PubMed ID: 2012453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of AIDS patients with zidovudine].
    Buijs L; Pietersz RN; van den Berg-Wolf MG; Reesink HW; ten Veen JH
    Ned Tijdschr Geneeskd; 1990 Jan; 134(2):71-5. PubMed ID: 2296325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of treatment with AZT of patients with AIDS and symptomatic HIV infection.
    Cox PH; Martin MA; Styer CM; Beall GN
    Nurse Pract; 1990 May; 15(5):36, 39-44. PubMed ID: 2342666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
    Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion associated AIDS in Mexico. Clinical spectrum, conditional latency distribution, and survival.
    Volkow P; Ponce de León S; Calva J; Ruiz-Palacios G; Mohar A
    Rev Invest Clin; 1993; 45(2):133-8. PubMed ID: 8337540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with zidovudine in patients with acquired immunodeficiency syndrome. Analysis of 117 cases. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas].
    Biedma D; Bascuñana A; Viciana P; Causse M; Torres Tortosa M; Lozano de León F; Pujol E; Pachón J
    Rev Clin Esp; 1992 Sep; 191(4):187-92. PubMed ID: 1439038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of generalists' slow adoption of zidovudine in clinical practice.
    Markson LE; Cosler LE; Turner BJ
    Arch Intern Med; 1994 Jul; 154(13):1497-504. PubMed ID: 8018005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zidovudine (Retrovir) update.
    Rachlis AR
    CMAJ; 1990 Dec; 143(11):1177-85. PubMed ID: 2224694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early versus deferred zidovudine monotherapy: impact on AIDS-free time and survival in the multicenter AIDS cohort study.
    Detels R; Muñoz A; Peng Y; Graham N; Mellors J; Phair J
    Antivir Ther; 1997 Jan; 2(1):21-9. PubMed ID: 11322263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems posed by therapeutic combinations of zidovudine during the treatment of opportunistic infections in AIDS].
    Meyohas MC; Eliaszewicz M; Stromboni C; Frottier J
    Therapie; 1989; 44(6):409-11. PubMed ID: 2623655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue.
    Mathé G; Pontiggia P; Orbach-Arbouys S; Triana K; Ambetima N; Morette C; Hallard M; Blanquet D
    Biomed Pharmacother; 1996; 50(5):220-7. PubMed ID: 8949403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset.
    Fiala M; Swartz J; Teklehaimanot S; Kermani V; Funnye AS; Sayre JW; Gornbein JA
    Lymphology; 1997 Sep; 30(3):128-36. PubMed ID: 9313205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Zidovudine. The current status of its evaluation].
    Kouzan S; Nebout T
    Therapie; 1989; 44(6):393-9. PubMed ID: 2696136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the pharmacovigilance follow-up of zidovudine].
    Gimenez S; Bagheri H; Marchou B; Massip P; Lafont J; Sorbette F; Armengaud M; Montastruc JL
    Therapie; 1990; 45(5):407-9. PubMed ID: 2260033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program.
    Creagh-Kirk T; Doi P; Andrews E; Nusinoff-Lehrman S; Tilson H; Hoth D; Barry DW
    JAMA; 1988 Nov; 260(20):3009-15. PubMed ID: 3263514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.